Dual sustained-release anticancer injection

A sustained-release injection and double-sustained-release technology, which is applied in the direction of antineoplastic drugs, pharmaceutical formulations, medical preparations containing active ingredients, etc., can solve the complex implantation process, the degradation and degeneration of anticancer active ingredients, and the inability to effectively remove tumor cells And other issues
CN101301264AInactive Publication Date: 2008-11-12济南基福医药科技有限公司

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
济南基福医药科技有限公司
Publication Date
2008-11-12
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

A double sustained release anticancer gel sustained release injection consists of anticancer medicine and amphiphilic block copolymer hydrogel, wherein the anticancer medicine comprises vincristine, vinorelbine, vinblastine, daunomycin, mitoxantrone, mitozolomide and temozolomide, etc., and exists in sustained release preparation injection in the forms of sustained release microsphere, microsphere or micropowder, i.e. the anticancer medicine in anticancer useful quantity is partly or completely wrapped inside the sustained release microsphere. Sustained release gel has temperature-sensitive gelling characteristics and is in the state of fluxible liquid in an environment with the temperature lower than body temperature; moreover, the sustained release gel can be automatically converted into non-flowing water-insoluble gel capable of biodegradation and absorption inside the body of a warm blood so as to slowly release medicine inside part of a tumor; the sustained release microsphere is propitious to release medicine smoothly and slowly, and double sustained release is propitious to control tumor cells entering a dormancy stage; moreover, the medicine which exists in the sustained release gel in the form of micropowder is propitious to release the medicine relatively faster and to control cells in faster proliferation. The double sustained release anticancer gel sustained release injection can used together with radiotherapeutic particle, etc.
Need to check novelty before this filing date? Find Prior Art

Description

(1) Technical field

[0001] The invention relates to a double slow-release anticancer gel injection, which belongs to the technical field of medicines. Specifically, the invention relates to a slow-release gel preparation capable of stably releasing anticancer drugs in local solid tumors, mainly a slow-release gel injection containing slow-release microspheres. It is an aqueous solution, which can become a semi-solid or solid gel in the body of a warm-blooded animal. The slow-release gel and slow-release microspheres can slowly release anticancer drugs locally on the tumor for several months. (2) Background technology

[0002] Although there are many ways to treat cancer, the living conditions of most patients have not been significantly improved. Among the various treatments, chemotherapy remains one of the commonly used options. Although conventional chemotherapy has been used for a long time, its therapeutic effect on solid tumors is uncertain. The fundamental problem is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More